ARLINGTON -- The Rangers are awaiting word on how outfielder Nelson Cruz may potentially be affected by Major League Baseball's investigation into Biogenesis, the Miami-area clinic that allegedly distributed performance-enhancing drugs to certain players.
Cruz and Brewers outfielder Ryan Braun are among the players who have been linked to the clinic, and on Monday, Braun became the first player in this case to be penalized when MLB announced that the outfielder will be suspended without pay for the remainder of the season.
"To my knowledge, there is nothing new on Nelson's situation," Rangers CEO Nolan Ryan said on Monday. "There is no insight on what the Commissioner's Office or Major League Baseball's position is on it. Because it is an ongoing investigation, Major League Baseball hasn't discussed it with anybody. They have been tight-lipped on it. That's their policy."
"I guess it is what it is," Cruz said. "I don't have any comment. I'm playing the same way. I come to the ballpark thinking about winning. That's my goal."
Cruz hit his 23rd homer in Monday night's series-opening 3-0 win over the Yankees, batting third and playing right field. Cruz is the only Rangers player to have been identified as being under investigation by the Commissioner's Office.
T.R. Sullivan is a reporter for MLB.com. Read his blog, Postcards from Elysian Fields, and follow him on Twitter @Sullivan_Ranger. Master Tesfatsion is an associate reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.